UnknownNot Applicable

Efficacy of a Single Injection of CTM for Post-Operative CMC Arthritis

United States50 participantsStarted 2023-03-07

Plain-language summary

The goal of this study is to determine the success rate of a single Carpometacarpal (CMC) thumb injection after arthroplasty surgery for primary osteoarthritis of the CMC joint.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Males or females age 18 or older
✓. Patients presenting for basilar thumb reconstruction surgery (any surgical technique)
✓. Patients who can consent to be a part of this study
✓. Patients who are able to return to the Indiana Hand to Shoulder Center or satellite location for follow up time points

Exclusion criteria

✕. Additional procedures at the same time
✕. Patients with previous basilar thumb reconstruction on the operative side (revision surgery)
✕. Chronic narcotic use
✕. Women who are pregnancy or breastfeeding
✕. Non-English speaking

What they're measuring

Narcotic Use

Timeframe: 6 Weeks

Trial details

NCT IDNCT06171529

SponsorIndiana Hand to Shoulder Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Osteoarthritis trials